Advances in Neuromuscular Monitoring Techniques in Anesthesiology: A 2025 Perspective. [PDF]
Grabarczyk Ł.
europepmc +1 more source
Evaluation of a New Routine Diagnostic Test for Immunoglobulin E Sensitization to Neuromuscular Blocking Agents [PDF]
D. Laroche+8 more
openalex +1 more source
Abstract Background Leucine‐rich repeat kinase 2 (LRRK2) p.L1795F variant was proposed as a genetic risk factor for Parkinson's disease (PD). However, its prevalence, phenotype, and origin remain unknown. Objective The aim was to evaluate the frequency and phenotype of p.L1795F in early‐onset PD (EOPD) and familial PD compared to healthy controls (HC ...
Miriam Ostrozovicova+35 more
wiley +1 more source
Neuromuscular Blocking Agents and Reversal Agents Usage, and Neuromuscular Blockade Monitoring in the Intensive Care Unit - Review Article. [PDF]
Szewczyk M+4 more
europepmc +1 more source
Adenosine potentiation of neuromuscular blocking agents in guinea-pigs
Keiichi Nitahara+5 more
openalex +1 more source
The effects of sevoflurane with propofol and remifentanil on tracheal intubation conditions without neuromuscular blocking agents [PDF]
Wook Jong Kim+6 more
openalex +1 more source
In this study we utilized proteomic profiling to investigate mechanisms linked to the cancer‐inhibitory effect of cranberry proanthocyanidins (CPACs) on reflux‐induced esophageal adenocarcinoma in a rat model. The results indicate that CPAC inhibits cancer through targeting multiple hallmarks of cancer known to be dysregulated in progression to ...
Yun Zhang+7 more
wiley +1 more source
A patient with myasthenia gravis showing lower sensitivity to rocuronium and earlier recovery of train-of-four responses on electromyography compared to acceleromyography: a case report. [PDF]
Murakami Y, Fujimoto M, Hirata N.
europepmc +1 more source
The new neuromuscular blocking agents: do they offer any advantages?
E. W. Moore, Jennifer M. Hunter
openalex +1 more source